The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
The Central Role of the Alternative Complement Pathway in Human Disease
Abstract
The complement system is increasingly recognized as important in the pathogenesis of tissue injury in vivo following immune, ischemic, or infectious insults. Within the complement system, three pathways are capable of initiating the processes that result in C3 activation: classical, alternative, and lectin. Although the roles that proinflammatory peptides and complexes generated during complement activation play in mediating disease processes have been studied extensively, the relative contributions of the three activating pathways is less well understood. Herein we examine recent evidence that the alternative complement pathway plays a key and, in most instances, obligate role in generating proinflammatory complement activation products in vivo. In addition, we discuss new concepts regarding the mechanisms by which the alternative pathway is activated in vivo, as recent clinical findings and experimental results have provided evidence that continuous active control of this pathway is necessary to prevent unintended targeting and injury to self tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,719
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
MOLECULAR ORGANIZATION AND FUNCTION OF THE COMPLEMENT SYSTEM
Müller-Eberhard, H. J. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001541 · Cited by 859
Arthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
Self-citationNoris, M., & Remuzzi, G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100861 · Cited by 635
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H., Pierangeli, S. S., Espinola, R., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 626
Self-citationComplement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 594
Self-citationComplement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 575
Self-citationLocal synthesis of complement component C3 regulates acute renal transplant rejection
Pratt, J. R., Basheer, S. A., & Sacks, S. H. (2002) · Nature Medicine · doi:10.1038/nm0602-582 · Cited by 534
A Critical Role for Murine Complement Regulator Crry in Fetomaternal Tolerance
Xu, C., Mao, D., Holers, V. M., Palanca, B., Cheng, A. M., & Molina, H. (2000) · Science · doi:10.1126/science.287.5452.498 · Cited by 524
Self-citationPickering, M. C., Cook, H. T., Warren, J., Bygrave, A. E., Moss, J., Walport, M. J., & Botto, M. (2002) · Nature Genetics · doi:10.1038/ng912 · Cited by 518
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Control of the Complement System
Uszewski, M. K., Farries, T. C., Lublin, D. M., Rooney, I. A., & Atkinson, J. P. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60868-8 · Cited by 500
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.
Molina, H., Holers, V. M., Li, B., Fung, Y., Mariathasan, S., Goellner, J., Strauss-Schoenberger, J., Karr, R. W., & Chaplin, D. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3357 · Cited by 465
Self-citationPredominant role for C5b-9 in renal ischemia/reperfusion injury
Zhou, W., Farrar, C. A., Abe, K., Pratt, J. R., Marsh, J. E., Wang, Y., Stahl, G. L., & Sacks, S. H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8621 · Cited by 465
Mellor, A. L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao, D., & Munn, D. H. (2001) · Nature Immunology · doi:10.1038/83183 · Cited by 423
Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Müslümanogğlu, M. H., Kavukcu, S., Filler, G., Pirson, Y., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135497100 · Cited by 405
Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update
Appel, G. B., Cook, H. T., Hageman, G., Jennette, J. C., Kashgarian, M., Kirschfink, M., Lambris, J. D., Lanning, L., Lutz, H. U., Meri, S., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010078 · Cited by 380
A Critical Role for Complement in Maintenance of Self-Tolerance
Prodeus, A. P., Goerg, S., Shen, L.-M., Pozdnyakova, O. O., Chu, L., Alicot, E. M., Goodnow, C. C., & Carroll, M. C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80669-x · Cited by 373
A role for the C3a anaphylatoxin receptor in the effector phase of asthma
Humbles, A. A., Lu, B., Nilsson, C. A., Lilly, C., Israel, E., Fujiwara, Y., Gerard, N. P., & Gerard, C. (2000) · Nature · doi:10.1038/35023175 · Cited by 353
Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16651 · Cited by 350
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
Fremeaux-Bacchi, V, Dragon-Durey, M.-A., Blouin, J., Vigneau, C., Kuypers, D., Boudailliez, B., Loirat, C., Rondeau, E., & Fridman, W. H. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019083 · Cited by 339
Wang, Y., Hu, Q., Madri, J. A., Rollins, S. A., Chodera, A., & Matis, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8563 · Cited by 336
Matsushita, M., Endo, Y., & Fujita, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2281 · Cited by 333
Structure and function of the pentraxins
Gewurz, H., Zhang, X.-H., & Lint, T. F. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80029-8 · Cited by 328
HARBOE, M., ULVUND, G., VIEN, L., FUNG, M., & MOLLNES, T. E. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02627.x · Cited by 319
Caprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, S., Daina, E., Remuzzi, G., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg363 · Cited by 306
Pérez-Caballero, D., González-Rubio, C., Gallardo, M. E., Vera, M., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2001) · The American Journal of Human Genetics · doi:10.1086/318201 · Cited by 293
Lack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice
Thurman, J. M., Ljubanovic, D., Edelstein, C. L., Gilkeson, G. S., & Holers, V. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1517 · Cited by 283
Self-citationComplement receptors and phagocytosis
Brown, E. J. (1991) · Current Opinion in Immunology · doi:10.1016/0952-7915(91)90081-b · Cited by 243
The Role of Complement in B Cell Activation and Tolerance
Carroll, M. C. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60908-6 · Cited by 238
Mullins, R. F., Aptsiauri, N., & Hageman, G. S. (2001) · Eye · doi:10.1038/eye.2001.142 · Cited by 231
Meri, S., Koistinen, V, Miettinen, A., Törnroth, T., & Seppälä, I. J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.4.939 · Cited by 223
Identification of the Second Heparin-Binding Domain in Human Complement Factor H
Blackmore, T. K., Hellwage, J., Sadlon, T. A., Higgs, N., Zipfel, P. F., Ward, H. M., & Gordon, D. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3342 · Cited by 222
Complement and diseases: Defective alternative pathway control results in kidney and eye diseases
Zipfel, P. F., Heinen, S., Józsi, M., & Skerka, C. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.06.015 · Cited by 218
Sánchez-Corral, P., Pérez-Caballero, D., Huarte, O., Simckes, A. M., Goicoechea, E., López-Trascasa, M., & de Córdoba, S. R. (2002) · The American Journal of Human Genetics · doi:10.1086/344515 · Cited by 218
Abrogation of the alternative complement pathway by targeted deletion of murine factor B
Matsumoto, M., Fukuda, W., Circolo, A., Goellner, J., Strauss-Schoenberger, J., Wang, X., Fujita, S., Hidvegi, T., Chaplin, D. D., & Colten, H. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8720 · Cited by 215
Women Fight Uphill Battle for Equity
Kinoshita, J. (1996) · Science · doi:10.1126/science.274.5284.50 · Cited by 213
Høgåsen, K., Jansen, J. H., Mollnes, T. E., Hovdenes, J., & Harboe, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117751 · Cited by 213
Watanabe, H., Garnier, G., Circolo, A., Wetsel, R. A., Ruiz, P., Holers, V. M., Boackle, S. A., Colten, H. R., & Gilkeson, G. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.786 · Cited by 207
Self-citationNeumann, H. P. H., Salzmann, M., Bohnert-Iwan, B., Mannuelian, T., Skerka, C., Lenk, D., Bender, B. U., Cybulla, M., Riegler, P., Königsrainer, A., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.9.676 · Cited by 206
Complement activation in factor D-deficient mice
Xu, Y., Ma, M., Ippolito, G. C., Schroeder, H. W., Carroll, M. C., & Volanakis, J. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261428398 · Cited by 198
KRUG, N., TSCHERNIG, T., ERPENBECK, V. J., HOHLFELD, J. M., & KÖHL, J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2010096 · Cited by 181
Fleming, S. D., Shea-Donohue, T., Guthridge, J. M., Kulik, L., Waldschmidt, T. J., Gipson, M. G., Tsokos, G. C., & Holers, V. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2126 · Cited by 178
Self-citationContribution of the innate immune system to autoimmune myocarditis: a role for complement
Kaya, Z., Afanasyeva, M., Wang, Y., Dohmen, K. M., Schlichting, J., Tretter, T., Fairweather, D., Holers, V. M., & Rose, N. R. (2001) · Nature Immunology · doi:10.1038/90686 · Cited by 175
Self-citationGiannakis, E., Jokiranta, T. S., Male, D. A., Ranganathan, S., Ormsby, R. J., Fischetti, V. A., Mold, C., & Gordon, D. L. (2003) · European Journal of Immunology · doi:10.1002/eji.200323541 · Cited by 166
Initiation of complement activation
Lachmann, P. J., & Hughes-Jones, N. C. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf01893018 · Cited by 164
Hamelmann, E., Takeda, K., Schwarze, J., Vella, A. T., Irvin, C. G., & Gelfand, E. W. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.21.4.3659 · Cited by 163
Thurman, J. M., Kraus, D. M., Girardi, G., Hourcade, D., Kang, H. J., Royer, P. A., Mitchell, L. M., Giclas, P. C., Salmon, J., Gilkeson, G., et al. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.043 · Cited by 162
Self-citationRole for the Alternative Complement Pathway in Ischemia/Reperfusion Injury
Stahl, G. L., Xu, Y., Hao, L., Miller, M., Buras, J. A., Fung, M., & Zhao, H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63839-4 · Cited by 160
Acute tubular necrosis is characterized by activation of the alternative pathway of complement
Thurman, J. M., Lucia, M. S., Ljubanović, D. G., & Holers, V. M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67109.x · Cited by 153
Self-citationComplement Deficiency Ameliorates Collagen-Induced Arthritis in Mice
Hietala, M. A., Jonsson, I., Tarkowski, A., Kleinau, S., & Pekna, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.454 · Cited by 142
Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes
Park, P., Haas, M., Cunningham, P. N., Bao, L., Alexander, J. J., & Quigg, R. J. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00160.2001 · Cited by 128
Effects of complement factor D deficiency on the renal disease of MRL/lpr mice
Elliott, M. K., Jarmi, T., Ruiz, P., Xu, Y., Holers, V. M., & Gilkeson, G. S. (2003) · Kidney International · doi:10.1111/j.1523-1755.2004.00371.x · Cited by 119
Self-citationPangburn, M. K., Pangburn, K. L. W., Koistinen, V., Meri, S., & Sharma, A. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4742 · Cited by 118
Complement receptor 2–mediated targeting of complement inhibitors to sites of complement activation
Song, H., He, C., Knaak, C., Guthridge, J. M., Holers, V. M., & Tomlinson, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17348 · Cited by 111
Self-citationInsights into the Pathogenesis of Asthma Utilizing Murine Models
Taube, C., Dakhama, A., & Gelfand, E. W. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000080899 · Cited by 109
Schwertz, R., Rother, U., Anders, D., Gretz, N., Scharer, K., & Kirschfink, M. (2001) · Pediatric Allergy and Immunology · doi:10.1034/j.1399-3038.2001.012003166.x · Cited by 108
Bao, L., Haas, M., Boackle, S. A., Kraus, D., Cunningham, P. N., Park, P., Alexander, J. J., Anderson, R. K., Culhane, K. K., Holers, V. M., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3601 · Cited by 107
Self-citationThe complement system as a therapeutic target in autoimmunity
Holers, V. M. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00034-2 · Cited by 102
Self-citationThe role of antibody in the activation of the alternative complement pathway
Ratnoff, W. D., Fearon, D. T., & Austen, K. F. (1983) · Springer Seminars in Immunopathology · doi:10.1007/bf02116280 · Cited by 96
Mao, D., Wu, X., Deppong, C. M., Friend, L. D., Dolecki, G. J., Nelson, D. M., & Molina, H. D. (2003) · Immunity · doi:10.1016/s1074-7613(03)00321-2 · Cited by 94
The alternative pathway of complement in disease: opportunities for therapeutic targeting
Holers, V. M., & Thurman, J. M. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.012 · Cited by 93
Self-citationRand, J. H. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0410 · Cited by 91
Bao, L., Haas, M., Kraus, D., Hack, B. K., Rakstang, J. K., Holers, V. M., & Quigg, R. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051597.27127.a1 · Cited by 88
Self-citationNomura, A., Nishikawa, K., Yuzawa, Y., Okada, H., Okada, N., Morgan, B. P., Piddlesden, S. J., Nadai, M., Hasegawa, T., & Matsuo, S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118291 · Cited by 77
Mammalian lectins in activation and clearance mechanisms involving the complement system
Reid, K. B. M., & TURNER, M. W. (1994) · Springer Seminars in Immunopathology · doi:10.1007/bf01837363 · Cited by 69
Complement resistance in microbes
Moffitt, M. C., & Frank, M. M. (1994) · Springer Seminars in Immunopathology · doi:10.1007/bf01837364 · Cited by 50
A War with the Molecules: Louis Pillemer and the History of Properdin
Ratnoff, W. D. (1980) · Perspectives in biology and medicine · doi:10.1353/pbm.1980.0036 · Cited by 22
Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3
Cited by
The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight
Markiewski, M. M., & Lambris, J. D. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070166 · Cited by 722
Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts
Gehrs, K. M., Anderson, D. H., Johnson, L. V., & Hageman, G. S. (2006) · Annals of Medicine · doi:10.1080/07853890600946724 · Cited by 631
Xiao, H., Schreiber, A., Heeringa, P., Falk, R. J., & Jennette, J. C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060573 · Cited by 579
Function, structure and therapeutic potential of complement C5a receptors
Monk, P. N., Scola, A., Madala, P., & Fairlie, D. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707332 · Cited by 404
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
DeCordova, S., Shastri, A., Tsolaki, A. G., Yasmin, H., Klein, L., Singh, S. K., & Kishore, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01402 · Cited by 346
Metadata
- Authors
- Thurman, J. M., & Holers, V. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-02-01
- Volume
- 176
- Issue
- 3
- Pages
- 1305-1310
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1563349777
- Cited by
- 432
- References
- 73
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.